Reuters logo
BRIEF-Amarin and HLS Therapeutics announce agreement to commercialize Vascepa in Canada
2017年9月25日 / 上午10点26分 / 25 天内

BRIEF-Amarin and HLS Therapeutics announce agreement to commercialize Vascepa in Canada

Sept 25 (Reuters) - Amarin Corporation Plc

* Amarin and HLS Therapeutics announce agreement to commercialize Vascepa in Canada

* Amarin Corporation Plc says ‍HLS will be responsible for regulatory and commercialization activities and associated costs​

* Amarin Corporation Plc says ‍terms of agreement include up-front and milestone payments to Amarin of up to U.S. $65.0 million​

* Amarin Corp - Amarin and HLS anticipate submitting application to Canadian regulatory authorities to seek approval to commercialize Vascepa in Canada

* Amarin Corporation Plc - Agreement also provides for HLS to pay Amarin tiered double digit royalties on net sales of Vascepa in Canada

* Amarin Corporation Plc - Amarin is obligated to supply finished product to HLS under negotiated supply terms

* Amarin Corporation -‍ Payments include non-refundable upfront payment of $5.0 million, development, regulatory, sale-based milestones totaling additional $60.0 million​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则"
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below